The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and¹⁸F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer

Abstract

There are no definitive modalities for detecting ALNM in T1 breast cancers to replace sentinel lymph node biopsy (SLNB). If ALNM is suspected based on cMRI and PET/CT, the axillary dissection without SLNB might be a better option because it is related to high possibilities of ALNM and large axillary metastatic volumes.